SRP-5051 (sodium)
Product Specifications
UNSPSC Description
SRP-5051 sodium is a next-generation antisense oligonucleotide of peptide phosphorodiamidate morpholino oligomer (PPMO). SRP-5051 targeting exon 51 skipping in Duchenne muscular dystrophy (DMD)[1].
Target Antigen
Others
Type
Oligonucleotides
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/srp-5051-sodium.html
Solubility
10 mM in H2O
Smiles
[SRP-5051 (sodium)]
Molecular Weight
12001.37
References & Citations
[1]Sarepta Therapeutics reports positive clinical results from phase 2 MOMENTUM study of SRP-5051 in patients with Duchenne muscular dystrophy amenable to skipping exon 51. News release. Sarepta Therapeutics. May 3, 2021. Accessed May 4, 2021.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-132585A/SRP-5051-sodium-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-132585A/
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
M01943-3-Biotin 100 μg
Anti-Calpain 1 Antibody Picoband® (monoclonal, 2I10) (Biotine Conjugate)
Ask
View Details 
MBS1402100-01 0.02 mg (E-Coli)
Recombinant Nocardia farcinica NADH-quinone oxidoreductase subunit C (nuoC)
Ask
View Details MBS1402100-02 0.1 mg (E-Coli)
Recombinant Nocardia farcinica NADH-quinone oxidoreductase subunit C (nuoC)
Ask
View Details MBS1402100-03 0.02 mg (Yeast)
Recombinant Nocardia farcinica NADH-quinone oxidoreductase subunit C (nuoC)
Ask
View Details MBS1402100-04 0.1 mg (Yeast)
Recombinant Nocardia farcinica NADH-quinone oxidoreductase subunit C (nuoC)
Ask
View Details